Atea Pharmaceuticals
AVIR · NASDAQ · Health Care · Pharmaceutical Preparations
Pharmaceutical Preparations company based in Boston, Ma.
As of Oct 21, 2026, OQRO holds for Atea Pharmaceuticals (AVIR) over the last 12 months: 62 insider filings, 0 Congress trades, 1 fund position and 0 federal contract awards. Most recent on file: Director purchased ~$25K of AVIR shares in the open market, traded May 18, 2026, filed May 22, 2026.
On the public record for Atea Pharmaceuticals over the 12 months to Oct 21, 2026: 2 clinical trials.
Example public filing
Director bought ~$25K
Polly A. Murphy, Director at Atea Pharmaceuticals, bought ~$25K of Atea Pharmaceuticals shares.
- ~$25K
- Approx. value · 6,100 sh @ $4.17
- 92K
- Holds after · shares reported
- Traded
- May 18, 2026
- Filed
- May 22, 2026
Data as of Oct 21, 2026. A real record from the official source, chosen as the most recent insider trade or, failing that, the most recent filing of another kind; not a recommendation.
On file for AVIR, last 12 months
- 62
- Insider filings
- 0
- Congress trades
- 1
- Fund positions
- 0
- Federal contracts
Records OQRO holds, counted by their date; a 13F position is counted once per quarter it is reported.
Insider buying and selling since 2020
Insiders of Atea Pharmaceuticals reported 8 open-market purchases and 14 sales since 2020; purchases in 4 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 1×1 trade | — |
| 2025 | 2×2 trades | — |
| 2024 | — | 12×12 trades |
| 2022 | — | 2×2 trades |
| 2021 | 1×1 trade | — |
| 2020 | 4×4 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
See the full picture with OQRO Pro.
63 records for Atea Pharmaceuticals in the last 12 months, each linked to its filing. Full histories, the screener, alerts for the companies you follow and Ask OQRO.
Latest disclosures
3 days free for first-time subscribers, then $9.99 a month. Nothing is charged today: your card is charged when the trial ends unless you cancel before, from your account. Secure payment by Stripe.
Public previews are free. Full research is OQRO Pro, with a 3-day free trial to start: your card is charged only when the trial ends.
Free account: get the written context of this page, built from its filings.
What this page holds
- Insider trades and planned sales
- Politician trades (House and Senate)
- Fund holdings from 13F filings
- Federal contracts, lobbying and short selling
- Full history and context, with a link to every filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Atea Pharmaceuticals insider trading
Have Atea Pharmaceuticals insiders bought shares recently?
No open-market purchase by an insider of Atea Pharmaceuticals was filed in the last 90 days. The latest on record was on May 22, 2026.
How often do Atea Pharmaceuticals insiders buy and sell shares?
Since 2020, Atea Pharmaceuticals insiders reported 8 open-market purchases and 14 sales on Forms 4 and 5, with purchases in 4 different years, most recently 2026.
Do members of Congress trade AVIR?
No trade in Atea Pharmaceuticals (AVIR) was disclosed by a member of Congress in the last 12 months.
When does Atea Pharmaceuticals report its next results?
Atea Pharmaceuticals's next results are expected on Nov 10, 2026. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
Where does this data come from?
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.